DK1197223T3 - Farmaceutisk præparat til forebyggelse, behandling eller udviklingsinhibition af simpel retinopati eller præproliferativ retinopati - Google Patents

Farmaceutisk præparat til forebyggelse, behandling eller udviklingsinhibition af simpel retinopati eller præproliferativ retinopati

Info

Publication number
DK1197223T3
DK1197223T3 DK00921056T DK00921056T DK1197223T3 DK 1197223 T3 DK1197223 T3 DK 1197223T3 DK 00921056 T DK00921056 T DK 00921056T DK 00921056 T DK00921056 T DK 00921056T DK 1197223 T3 DK1197223 T3 DK 1197223T3
Authority
DK
Denmark
Prior art keywords
retinopathy
prevention
treatment
pharmaceutical preparation
preproliferative
Prior art date
Application number
DK00921056T
Other languages
Danish (da)
English (en)
Inventor
Shizue Nakagawa
Yasutaka Nagisa
Hitoshi Ikeda
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of DK1197223T3 publication Critical patent/DK1197223T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00921056T 1999-04-28 2000-04-27 Farmaceutisk præparat til forebyggelse, behandling eller udviklingsinhibition af simpel retinopati eller præproliferativ retinopati DK1197223T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12149899 1999-04-28
PCT/JP2000/002766 WO2000066161A1 (fr) 1999-04-28 2000-04-27 Preventifs / remedes / inhibiteurs de progression pour retinopathie simplex ou retinopathie preproliferante

Publications (1)

Publication Number Publication Date
DK1197223T3 true DK1197223T3 (da) 2005-05-30

Family

ID=14812676

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00921056T DK1197223T3 (da) 1999-04-28 2000-04-27 Farmaceutisk præparat til forebyggelse, behandling eller udviklingsinhibition af simpel retinopati eller præproliferativ retinopati

Country Status (23)

Country Link
US (2) US7064141B1 (cs)
EP (1) EP1197223B1 (cs)
KR (1) KR100865059B1 (cs)
CN (1) CN1172719C (cs)
AT (1) ATE289204T1 (cs)
AU (1) AU774799B2 (cs)
BR (1) BR0010084A (cs)
CA (1) CA2371554C (cs)
CZ (1) CZ301913B6 (cs)
DE (1) DE60018186T2 (cs)
DK (1) DK1197223T3 (cs)
ES (1) ES2233362T3 (cs)
HU (1) HU226948B1 (cs)
MX (1) MXPA01010923A (cs)
NO (1) NO327446B1 (cs)
NZ (1) NZ514855A (cs)
PL (1) PL196895B1 (cs)
PT (1) PT1197223E (cs)
RU (1) RU2239454C2 (cs)
SI (1) SI1197223T1 (cs)
SK (1) SK286859B6 (cs)
WO (1) WO2000066161A1 (cs)
ZA (1) ZA200108527B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452176A4 (en) * 2001-12-03 2009-01-21 Takeda Pharmaceutical AGENTS FOR IMPROVING THE STATE OF RESISTANCE OF INSULIN
JP4484427B2 (ja) * 2001-12-03 2010-06-16 武田薬品工業株式会社 インスリン抵抗性改善剤
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
US8980870B2 (en) 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
DE10335027A1 (de) * 2003-07-31 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Angiotensin II Rezeptor Antagonisten
EP2517728B1 (en) * 2003-04-15 2015-01-28 Daiichi Sankyo Company, Limited Olmesartan medoxomil for preventing or treating angiogenic eye diseases
US20050038093A1 (en) * 2003-05-02 2005-02-17 Boehringer Ingelheim International Gmbh Treating diabetic retinopathy with angiotensin II receptor blockers
DK1784181T3 (da) 2004-08-31 2013-09-02 Newsouth Innovations Pty Ltd VEGF-hæmning
AU2005300787B2 (en) * 2004-11-05 2011-05-26 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and amlodipine
PT1872783E (pt) * 2005-04-21 2012-01-16 Santen Pharmaceutical Co Ltd Agente terapêutico para distúrbio queratoconjuntivo
CN101312962A (zh) * 2005-12-06 2008-11-26 参天制药株式会社 角膜结膜病变的治疗剂
EP2124903B1 (en) * 2007-03-28 2019-06-12 Takeda Pharmaceutical Company Limited Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027211D0 (en) 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
US5614519A (en) 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
DE4201554A1 (de) * 1992-01-22 1993-07-29 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9110635D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Chemical compounds
IL104755A0 (en) * 1992-02-17 1993-06-10 Ciba Geigy Ag Treatment of glaucoma
GB9223860D0 (en) * 1992-11-13 1993-01-06 Glaxo Group Ltd Chemical compounds
CZ154994A3 (en) 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
JPH0789957A (ja) 1993-09-22 1995-04-04 Nissan Chem Ind Ltd ビフェニルメチルアミン誘導体
AU1423795A (en) 1994-02-08 1995-08-29 Novartis Ag Treatment of normotensive glaucoma with angiotensin ii antagonists
JPH09210183A (ja) * 1996-01-31 1997-08-12 Suzuki Motor Corp 動力伝達装置
HU228263B1 (en) * 1996-03-29 2013-02-28 Smithkline Beecham Corp Eprosartan dihydrate and a process for its production and formulation
PL193365B1 (pl) * 1996-04-05 2007-02-28 Takeda Pharmaceutical Kompozycja farmaceutyczna do zapobiegania lub zwalczania chorób związanych z angiotensyną II oraz zastosowanie związków do wytwarzania leku do zapobiegania lub zwalczania chorób związanych z angiotensyną II
TW416953B (en) 1996-09-25 2001-01-01 Takeda Chemical Industries Ltd Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use
EP0855392A3 (de) 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
WO1999000383A1 (en) * 1997-06-27 1999-01-07 Smithkline Beecham Corporation Eprosartan monohydrate
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
ES2273433T3 (es) * 1997-08-06 2007-05-01 Smithkline Beecham Corporation Complejo por neutralizacion de cargas con arginilo de eprosartan y procedimiento para su produccion y formulacion.
CN1291888A (zh) 1998-03-04 2001-04-18 武田药品工业株式会社 Aⅱ拮抗剂的缓释制剂、其制备和用途
CA2678722C (en) 1998-07-10 2013-08-27 Novartis Ag Antihypertensive combination of valsartan and a calcium channel blocker
FR2783422A1 (fr) 1998-09-21 2000-03-24 Sanofi Sa Composition pharmaceutique contenant un antagoniste des recepteurs at1 de l'angiotensine ii et un antiagregant plaquettaire
JP2000159671A (ja) 1998-12-01 2000-06-13 Takeda Chem Ind Ltd 血管新生阻害剤

Also Published As

Publication number Publication date
NO20015257L (no) 2001-10-26
PL350554A1 (en) 2002-12-16
EP1197223B1 (en) 2005-02-16
PT1197223E (pt) 2005-04-29
SK15452001A3 (sk) 2002-04-04
SK286859B6 (sk) 2009-06-05
HU226948B1 (en) 2010-03-29
EP1197223A1 (en) 2002-04-17
CZ301913B6 (cs) 2010-07-28
WO2000066161A1 (fr) 2000-11-09
EP1197223A4 (en) 2003-10-29
DE60018186T2 (de) 2005-12-29
NZ514855A (en) 2004-01-30
ATE289204T1 (de) 2005-03-15
RU2239454C2 (ru) 2004-11-10
AU774799B2 (en) 2004-07-08
AU4143400A (en) 2000-11-17
ES2233362T3 (es) 2005-06-16
PL196895B1 (pl) 2008-02-29
KR100865059B1 (ko) 2008-10-23
CN1172719C (zh) 2004-10-27
CN1348385A (zh) 2002-05-08
HUP0200890A3 (en) 2002-12-28
BR0010084A (pt) 2002-01-15
MXPA01010923A (es) 2002-06-21
CA2371554A1 (en) 2000-11-09
US7064141B1 (en) 2006-06-20
CZ20013804A3 (cs) 2002-04-17
KR20020015315A (ko) 2002-02-27
DE60018186D1 (de) 2005-03-24
SI1197223T1 (cs) 2005-08-31
HUP0200890A2 (hu) 2002-11-28
ZA200108527B (en) 2002-10-17
CA2371554C (en) 2009-06-09
NO327446B1 (no) 2009-06-29
US20060189669A1 (en) 2006-08-24
NO20015257D0 (no) 2001-10-26

Similar Documents

Publication Publication Date Title
BR0109703A (pt) Derivados de piperazina
DE69925256D1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
BR9908004A (pt) Composto, composição e método para prevençãoou supressão de uma infecção viral
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
ATE293609T1 (de) Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität
GB9801690D0 (en) Therapeutic agents
PT1200412E (pt) Agentes anti-proliferativos de imidazole
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
EE200200172A (et) Ühendid isheemia ravimiseks
ATE467627T1 (de) Therapeutische piperazinverbindungen
BR9914390B1 (pt) benzoil-ciclohexano-dionas, agentes herbicidas apresentando as mesmas, processo para o combate de plantas indesejadas e aplicação dos referidos compostos.
ATE425139T1 (de) Benzamidinderivate
IT1311922B1 (it) Composti farmaceutici.
DK1197223T3 (da) Farmaceutisk præparat til forebyggelse, behandling eller udviklingsinhibition af simpel retinopati eller præproliferativ retinopati
DE60005031D1 (de) Partikel mit kontrollierter freisetzungsrate
DE60112960D1 (de) Kondensierte pyridoindolderivate
BR0215067A (pt) Piridoquinoxalinas antivirais
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
TR199901017A2 (xx) B�cek ilac� terkibi.
BR0207102A (pt) Forma cristalina, composição farmacêutica, uso de uma forma cristalina, e, método para a prevenção ou o tratamento de doença
DK0896822T3 (da) 4-aminopyrrol (3,2-d) pyrimidiner som neuropeptide Y receptorantagonister
DK1224181T3 (da) Substituerede pyrroler som antiproliferative midler til behandling af cancer
WO2001011968A3 (en) Heterocyclic spiro compounds as pesticides
BR0007395B1 (pt) compostos de s-nitrosotióis como agentes para o tratamento de disfunções circulatórias.